New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without
Oncology January 21,2024
Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without
Oncology January 21,2024
Breaks in 'junk' DNA give scientists new insight into neurological disorders

Breaks in 'junk' DNA give scientists new insight into neurological disorders

byUniversity of SheffieldCredit: Pixabay/CC0 Public DomainJunk DNA could unlock new treatments for neurological disorders as scientists discover its breaks and repairs affect our protection agai
Neurology January 21,2024
Breaks in 'junk' DNA give scientists new insight into neurological disorders

Breaks in 'junk' DNA give scientists new insight into neurological disorders

byUniversity of SheffieldCredit: Pixabay/CC0 Public DomainJunk DNA could unlock new treatments for neurological disorders as scientists discover its breaks and repairs affect our protection agai
Neurology January 21,2024
A step towards precision oncology for patients with metastatic urothelial carcinoma

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
Oncology January 21,2024
A step towards precision oncology for patients with metastatic urothelial carcinoma

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
Oncology January 21,2024
AAN issues evidence-in-focus article on aducanumab

AAN issues evidence-in-focus article on aducanumab

byAmerican Academy of NeurologyCredit: Pixabay/Pete Linforth.To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's d
Neurology January 21,2024
AAN issues evidence-in-focus article on aducanumab

AAN issues evidence-in-focus article on aducanumab

byAmerican Academy of NeurologyCredit: Pixabay/Pete Linforth.To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's d
Neurology January 21,2024
Type 2 diabetes accelerates brain aging and cognitive decline

Type 2 diabetes accelerates brain aging and cognitive decline

byeLifeThis image shows the effects of aging effects on the brain, further exacerbated in type 2 diabetes. Credit: Lilianne Mujica-Parodi (CC BY 4.0)Scientists have demonstrated that normal brai
Neurology January 21,2024
Type 2 diabetes accelerates brain aging and cognitive decline

Type 2 diabetes accelerates brain aging and cognitive decline

byeLifeThis image shows the effects of aging effects on the brain, further exacerbated in type 2 diabetes. Credit: Lilianne Mujica-Parodi (CC BY 4.0)Scientists have demonstrated that normal brai
Neurology January 21,2024
13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

by Elana GotkineThirteen percent of patients with definite anti-N-methyl-D-aspartate receptor encephalitis (ANMDARE) have suicidal thoughts and behaviors during the acute phase of the disease, accordi
Neurology January 21,2024
13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

by Elana GotkineThirteen percent of patients with definite anti-N-methyl-D-aspartate receptor encephalitis (ANMDARE) have suicidal thoughts and behaviors during the acute phase of the disease, accordi
Neurology January 21,2024
'Jumping' genes yield new clues to origins of neurodegenerative disease

'Jumping' genes yield new clues to origins of neurodegenerative disease

by Bill Hathaway,Yale UniversityGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.011Massive, repetitive stretches of DNA in the human genome may harbor hints ab
Neurology January 21,2024
'Jumping' genes yield new clues to origins of neurodegenerative disease

'Jumping' genes yield new clues to origins of neurodegenerative disease

by Bill Hathaway,Yale UniversityGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.011Massive, repetitive stretches of DNA in the human genome may harbor hints ab
Neurology January 21,2024
Anti-aging effects of 1,5-anhydro-D-fructose on brain diseases via AMPK activation

Anti-aging effects of 1,5-anhydro-D-fructose on brain diseases via AMPK activation

by Impact Journals LLCSchema of various effects and identical mechanisms of 1,5-AF in models of aging-associated brain diseases. Credit:Aging(2023). DOI: 10.18632/aging.205228A new researc
Neurology January 21,2024
Anti-aging effects of 1,5-anhydro-D-fructose on brain diseases via AMPK activation

Anti-aging effects of 1,5-anhydro-D-fructose on brain diseases via AMPK activation

by Impact Journals LLCSchema of various effects and identical mechanisms of 1,5-AF in models of aging-associated brain diseases. Credit:Aging(2023). DOI: 10.18632/aging.205228A new researc
Neurology January 21,2024
'Biohybrid' device could restore function in paralyzed limbs

'Biohybrid' device could restore function in paralyzed limbs

byUniversity of CambridgeIn a study carried out in rats, researchers from the University of Cambridge used a biohybrid device to improve the connection between the brain and paralyzed limbs. The
Neurology January 21,2024
'Biohybrid' device could restore function in paralyzed limbs

'Biohybrid' device could restore function in paralyzed limbs

byUniversity of CambridgeIn a study carried out in rats, researchers from the University of Cambridge used a biohybrid device to improve the connection between the brain and paralyzed limbs. The
Neurology January 21,2024
Children as young as 3 to 5 recognize broken promises

Children as young as 3 to 5 recognize broken promises

byDuke UniversityCredit: Unsplash/CC0 Public DomainWhen it comes to broken promises, children as young as three to five recognize that some excuses are better than others. It turns out children
Neurology January 21,2024
Children as young as 3 to 5 recognize broken promises

Children as young as 3 to 5 recognize broken promises

byDuke UniversityCredit: Unsplash/CC0 Public DomainWhen it comes to broken promises, children as young as three to five recognize that some excuses are better than others. It turns out children
Neurology January 21,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com